Literature DB >> 15950153

ATF5 regulates the proliferation and differentiation of oligodendrocytes.

Jeffrey L Mason1, James M Angelastro, Tatyana N Ignatova, Valery G Kukekov, Grace Lin, Lloyd A Greene, James E Goldman.   

Abstract

The transcription factor ATF5 is expressed in cells of the embryonic and neonatal ventricular zone/subventricular zone (VZ/SVZ), and must be down-regulated for their differentiation into neurons and astrocytes. Here, we show that ATF5 plays a major role in directing oligodendrocyte development. ATF5 is expressed by oligodendrocyte precursors but is absent from mature oligodendroglia. Constitutively expressed ATF5 maintains SVZ cells and O4(+) oligodendrocyte precursors in cycle and inhibits their differentiation into oligodendrocytes in vitro and in vivo. In contrast, ATF5 loss-of-function (LOF; produced by a dominant-negative form of the protein) accelerates oligodendrocyte differentiation of O4(+) cells in vitro and of SVZ cells in vivo. Significantly, the accelerated oligodendrocyte differentiation promoted by ATF5 LOF in vivo results in aberrant migration. Thus, appropriately regulated expression of ATF5 is required for proper expansion of oligodendroglial progenitors as well as for their timely differentiation. Regulation of oligodendrocyte, astrocyte, and neuronal differentiation indicates that ATF5 operates as a general regulator of the timing of differentiation, independent of cell lineage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950153     DOI: 10.1016/j.mcn.2005.03.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  28 in total

1.  BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.

Authors:  Douglas Dluzen; Guangfu Li; Diana Tacelosky; Matthew Moreau; David X Liu
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

Review 2.  Transcription factors and neural stem cell self-renewal, growth and differentiation.

Authors:  Sohail Ahmed; Hui Theng Gan; Chen Sok Lam; Anuradha Poonepalli; Srinivas Ramasamy; Yvonne Tay; Muly Tham; Yuan Hong Yu
Journal:  Cell Adh Migr       Date:  2009-10-27       Impact factor: 3.405

3.  Expression patterns of activating transcription factor 5 (atf5a and atf5b) in zebrafish.

Authors:  Roberto Rodríguez-Morales; Viveca Vélez-Negrón; Aranza Torrado-Tapias; Gaurav Varshney; Martine Behra
Journal:  Gene Expr Patterns       Date:  2020-07-11       Impact factor: 1.224

4.  Proceedings of German Society for Stem Cell Research (PGSSCR).

Authors: 
Journal:  J Stem Cells Regen Med       Date:  2007-05-16

5.  Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells.

Authors:  Florian A Siebzehnrubl; Rolf Buslei; Ilker Y Eyupoglu; Sebastian Seufert; Eric Hahnen; Ingmar Blumcke
Journal:  Exp Brain Res       Date:  2007-01-10       Impact factor: 1.972

6.  Expression and targeting of transcription factor ATF5 in dog gliomas.

Authors:  D York; C D Sproul; N Chikere; P J Dickinson; J M Angelastro
Journal:  Vet Comp Oncol       Date:  2017-05-08       Impact factor: 2.613

7.  Transcription factor ATF5 is required for terminal differentiation and survival of olfactory sensory neurons.

Authors:  Shu-Zong Wang; Jianhong Ou; Lihua J Zhu; Michael R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

8.  p300-dependent acetylation of activating transcription factor 5 enhances C/EBPβ transactivation of C/EBPα during 3T3-L1 differentiation.

Authors:  Yue Zhao; Ya-Dong Zhang; You-You Zhang; Shu-Wen Qian; Zhi-Chun Zhang; Shu-Fen Li; Liang Guo; Yuan Liu; Bo Wen; Qun-Ying Lei; Qi-Qun Tang; Xi Li
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

Review 9.  The transcription factor ATF5: role in neurodevelopment and neural tumors.

Authors:  Lloyd A Greene; Hae Young Lee; James M Angelastro
Journal:  J Neurochem       Date:  2008-11-15       Impact factor: 5.372

10.  Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells.

Authors:  Guangfu Li; Wenhong Li; James M Angelastro; Lloyd A Greene; David X Liu
Journal:  Mol Cancer Res       Date:  2009-06-16       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.